Bio-Techne Corporation (NASDAQ:TECH) Q1 2020 Earnings Conference Call October 29, 2019 9:00 AM ET Company Participants David Clair - Senior Director, Corporate Development Charles Kummeth - President and CEO Jim Hippel - CFO Conference Call Participants Puneet Souda - SVB Leerink Catherine Schulte - Robert W. Baird Unidentified Analyst - Craig-Hallum Capital Group Paul Knight - Janney Montgomery Operator Good morning and welcome to the Bio-Techne Earnings Conference Call for the First Quarter of Fiscal Year ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2019, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period Commission file number 0-17272 BIO-TECHNE CORPORATION (Exact name of registrant as specified in its charter) Minnesota 41-1427402 (State or other jurisdiction of inco ...

Bio-Techne Corporation (NASDAQ:TECH) Q4 2019 Earnings Conference Call August 6, 2019 9:00 AM ET Company Participants Chuck Kummeth - CEO Jim Hippel - CFO Conference Call Participants Puneet Souda - SVB Leerink Catherine Schulte - Baird Dan Leonard - Deutsche Bank Patrick Donnelly - Goldman Sachs Alex Nowak - Craig-Hallum Capital Group Paul Knight - Janney Operator Good morning and welcome to the Bio-Techne Earnings Conference Call for the Fourth Quarter of Fiscal Year 2019. At this time, all participants ha ...

Click to edit Master title style biotechne® Corporate Presentation June 2019 Business Overview B U S I N E S S O V E R V I E W C O R P O R A T E Legacy Revenue At a Glance: | --- | --- | --- | |------------------------------------|-------|-------| | | | | | | | | | President and CEO: Chuck Kummeth | | | | Headquarters: Minneapolis, MN | 25% | | | Number of Employees: ~2,100 | | | | World Wide Presence: 35 Locations | | | | FY2018 Revenues: $643 million | | | | NASDAQ: TECH | 10% | | | Market Cap: ~$7B | | 6 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17272 BIO-TECHNE CORPORATION (Exact name of registrant as specified in its charter) Minnesota 41-1427402 (State or other jur ...

Bio-Techne Corp (NASDAQ:TECH) Q3 2019 Earnings Conference Call April 30, 2019 9:00 AM ET Company Participants James Hippel - SVP, Finance & CFO Charles Kummeth - CEO, President & Director Conference Call Participants Puneet Souda - SVB Leerink Catherine Schulte - Robert W. Baird & Co. Michael Sarcone - Deutsche Bank Charles Steinman - Goldman Sachs Group Alexander Nowak - Craig-Hallum Capital Group Operator Good morning, and welcome to Bio-Techne Earnings Conference Call for the third quarter of fiscal year ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2018, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17272 BIO-TECHNE CORPORATION (Exact name of registrant as specified in its charter) Minnesota 41-1427402 (State or other ...

Bio-Techne Corp. (NASDAQ:TECH) Q2 2019 Earnings Conference Call February 5, 2019 9:00 AM ET Company Participants Chuck Kummeth - Chief Executive Officer Jim Hippel - Chief Financial Officer Conference Call Participants Daniel Arias - Citigroup Puneet Souda - FCB Leerink Catherine Schulte - Baird Drew Jones - Stephens Dan Leonard - Deutsche Bank Alex Nowak - Craig-Hallum Capital Group Operator Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2019. At ...

Click to edit Master title style biotechne® Corporate Presentation January 2019 Safe Harbor Cautionary Statements This presentation contains "forward-looking statements" within the meaning of the federal securities laws. Except for historical information contained herein, the statements in this presentation are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements made herein relate to, among other things, future s ...